| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 2022-06-03 | 12:05 to 13:41 | BRAVS ROOM |
SURGICAL RETINA Surgical Case - BRAVS CHALLENGING SURGICAL CASES (46) |
Chairperson | ||
| 2022-06-03 | 19:07 to 19:37 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Opening Ceremony - OPENING CEREMONY (6) |
Chairperson | ||
| 2022-06-04 | 11:50 to 13:02 | BRAVS ROOM |
SURGICAL RETINA Panel - BRAVS PANEL 02 – SURGICAL RETINA (19) |
11:50 to 11:54 | Macular surgery#1 | Presenter |
| 2022-06-04 | 16:38 to 17:50 | BRAVS ROOM |
SURGICAL RETINA Panel - BRAVS PANEL 04 – SURGICAL RETINA (23) |
17:23 to 17:27 | Diabetic vitrectomy#2 | Presenter |
| 2022-06-05 | 12:26 to 13:26 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: LONGER-ACTING THERAPIES: OPTIMISING nAMD MANAGEMENT (59) |
12:30 to 12:33 | Addressing the unmet need for longer-acting therapies for nAMD | Speaker |
| 2022-06-05 | 12:26 to 13:26 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: LONGER-ACTING THERAPIES: OPTIMISING nAMD MANAGEMENT (59) |
12:33 to 12:36 | Continuous delivery of anti–VEGF-A | Speaker |
| 2022-06-05 | 12:26 to 13:26 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: LONGER-ACTING THERAPIES: OPTIMISING nAMD MANAGEMENT (59) |
12:54 to 13:09 | Panel discussion | Discussant |